From August 8-9, 2024, the Molecular Surveillance of Malaria in Tanzania Phase 2 (MSMT2) project team at the Ifakara Health Institute convened to strategize the next phase of the project. 

Funded by the Bill and Melinda Gates Foundation, this project is implemented by Ifakara in collaboration with the Ministry of Health through the National Malaria Control Programme, the President’s Office - Regional Administration and Local Government, and the National Institute for Medical Research (NIMR).

Led by Dr. Deusdedith Ishengoma, the project Principal Investigator, the project aims to inform the National Malaria Control Program (NMCP) through extensive national surveillance of antimalarial resistance and pfhrp2/3 gene deletions.

The session provided an opportunity for the team to familiarize themselves with Ifakara’s policies and regulations, draft work plans for 2024/25, and plan for upcoming project activities.

Attendees include Priscilla Mlay, the Project Administrator; Celine Mandara, Co-Principal Investigator (Co-PI) and Research Coordinator (RC); Christopher Masaka, Deputy Finance Manager (DFM); Rashid Madebe, Lab Manager (LM); Obedi Kaondo, Operations Finance Manager (OFM); Misago Seth, Co-Principal Investigator (Co-PI) and Lab Coordinator (LC); and Solomon Mwakasungula, Assistant Project Coordinator.